Internship: Value Evidence Analyst, Belgium - 2023

작업 내용

Site Name: Belgium-Wavre

Posted Date: Nov 24 2022

Exciting minds with our Internship Programme

Education required: You are regularly enrolled in a Bachelor/Master in scientific field in an Educational Establishment located in Europe.

Language requirement: English & French

Skills required :

• Ability to perform systematic literature review
• Strong analytical and data synthesis skills
• Knowledge of health economics basics
• Able to work independently
• Effective verbal and written communication skills
• Work on Excel
  
  

Start date: as soon as possible

Duration:3 to 6 months

Requisite: The internship must be mandatory & done in the framework of the curriculum, for which an agreement must be signed between GSK, the student and the Educational Establishment.

Remuneration: according to Belgian legal requirements, the internship will not be paid. However, some expenses will be reimbursed.

Application deadline: We recommend you apply as soon as possible, because we accept ongoing applications, and we will close the position once we have enough matching candidates

What will you do?

On our internship programme you’ll receive tailored on-the-job training from industry experts combined with early responsibility to help you to develop and progress.

Your duties might include:

• Exploring the literature on Chickenpox cost-of-illness
• Developing and/or updating of previously conducted systematic literature review
• Synthetizing of findings and selection of data to be used in the model
• Developing the model specifications document which would lay out the country of interest, the
• Creating the model and parametrizing it with the relevant data identified in the SLR and selected in the model specifications document
• Assess the uncertainty associated with the results by running sensitivity and scenario analyses, and by comparing findings with evidence published in similar models, or in cost-effectiveness analyses
• Interact with key cross-functional stakeholders in the organization under supervision
  
  

GSK will offer to a master student to design and conduct a cost-of-illness analysis which goal would be to estimate the overall burden associated with varicella infections, including direct and indirect costs due to mild and complicated varicella, impact on caregivers, and potentially include VZV reactivation impact.

Why GSK?

Want to solve some of the world’s biggest health challenges?

With over 300 years of innovation, we’re a science-led global healthcare company that delivers billions of innovative products each year. Join us and help millions of people do more, feel better, live longer.

We are one of the largest vaccine companies in the world, providing vaccines that help protect people at all stages of life. Our R&D focuses on the development of vaccines against infectious diseases that combine high medical needs and strong commercial potential. Our Vaccines business has a portfolio of over 20 vaccines to help protect people against a range of diseases throughout their lives. We provide these vaccines to people living in more than 160 countries. We have a pipeline of 17 candidate vaccines in development as of fiscal year 2020, including three for the prevention of respiratory syncytial virus (RSV). In October 2017, our shingles vaccine, Shingrix, received regulatory approval in Canada and the United States.

We prevent and treat diseases with vaccines and specialized and general medicines. We focus on immune system science, human genetics and advanced technologies, investing in four core therapeutic areas (infectious disease, HIV, oncology and immunology/respiratory) and future opportunities to impact health in large scale. Our pipeline currently includes 57 vaccines and drugs, primarily in the areas of infectious diseases, oncology and immune-mediated diseases.

We operate on the multiplier effect of Science x Technology x Culture. This approach helps us accelerate the pace at which we develop and deliver transformative medicines, prioritizing molecules with a higher probability of success and terminating less promising programs. It also allows us to focus more on specialty medicines in areas such as oncology.

Apply now!

We’re 100% open to all talent – whatever your gender, marital status, religion, age, colour, race, sexual orientation, nationality or disability. We want to recruit the right people for GSK from the widest possible backgrounds, so we can better serve the diversity of our patients and consumers. And also because it’s the right thing to do.

If you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK’s commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.